Cargando…

Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics

Sharks and other cartilaginous fish are the phylogenetically oldest living organisms that have antibodies as part of their adaptive immune system. As part of their humoral adaptive immune response, they produce an immunoglobulin, the so-called immunoglobulin new antigen receptor (IgNAR), a heavy-cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernández-Quintero, Monica L., Seidler, Clarissa A., Quoika, Patrick K., Liedl, Klaus R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093575/
https://www.ncbi.nlm.nih.gov/pubmed/33959632
http://dx.doi.org/10.3389/fmolb.2021.639166
_version_ 1783687839029919744
author Fernández-Quintero, Monica L.
Seidler, Clarissa A.
Quoika, Patrick K.
Liedl, Klaus R.
author_facet Fernández-Quintero, Monica L.
Seidler, Clarissa A.
Quoika, Patrick K.
Liedl, Klaus R.
author_sort Fernández-Quintero, Monica L.
collection PubMed
description Sharks and other cartilaginous fish are the phylogenetically oldest living organisms that have antibodies as part of their adaptive immune system. As part of their humoral adaptive immune response, they produce an immunoglobulin, the so-called immunoglobulin new antigen receptor (IgNAR), a heavy-chain only antibody. The variable domain of an IgNAR, also known as V(NAR), binds the antigen as an independent soluble domain. In this study, we structurally and dynamically characterized the affinity maturation mechanism of the germline and somatically matured (PBLA8) V(NAR) to better understand their function and their applicability as therapeutics. We observed a substantial rigidification upon affinity maturation, which is accompanied by a higher number of contacts, thereby contributing to the decrease in flexibility. Considering the static x-ray structures, the observed rigidification is not obvious, as especially the mutated residues undergo conformational changes during the simulation, resulting in an even stronger network of stabilizing interactions. Additionally, the simulations of the V(NAR) in complex with the hen egg-white lysozyme show that the V(NAR) antibodies evidently follow the concept of conformational selection, as the binding-competent state already preexisted even without the presence of the antigen. To have a more detailed description of antibody–antigen recognition, we also present here the binding/unbinding mechanism between the hen egg-white lysozyme and both the germline and matured V(NAR)s. Upon maturation, we observed a substantial increase in the resulting dissociation-free energy barrier. Furthermore, we were able to kinetically and thermodynamically describe the binding process and did not only identify a two-step binding mechanism, but we also found a strong population shift upon affinity maturation toward the native binding pose.
format Online
Article
Text
id pubmed-8093575
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80935752021-05-05 Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics Fernández-Quintero, Monica L. Seidler, Clarissa A. Quoika, Patrick K. Liedl, Klaus R. Front Mol Biosci Molecular Biosciences Sharks and other cartilaginous fish are the phylogenetically oldest living organisms that have antibodies as part of their adaptive immune system. As part of their humoral adaptive immune response, they produce an immunoglobulin, the so-called immunoglobulin new antigen receptor (IgNAR), a heavy-chain only antibody. The variable domain of an IgNAR, also known as V(NAR), binds the antigen as an independent soluble domain. In this study, we structurally and dynamically characterized the affinity maturation mechanism of the germline and somatically matured (PBLA8) V(NAR) to better understand their function and their applicability as therapeutics. We observed a substantial rigidification upon affinity maturation, which is accompanied by a higher number of contacts, thereby contributing to the decrease in flexibility. Considering the static x-ray structures, the observed rigidification is not obvious, as especially the mutated residues undergo conformational changes during the simulation, resulting in an even stronger network of stabilizing interactions. Additionally, the simulations of the V(NAR) in complex with the hen egg-white lysozyme show that the V(NAR) antibodies evidently follow the concept of conformational selection, as the binding-competent state already preexisted even without the presence of the antigen. To have a more detailed description of antibody–antigen recognition, we also present here the binding/unbinding mechanism between the hen egg-white lysozyme and both the germline and matured V(NAR)s. Upon maturation, we observed a substantial increase in the resulting dissociation-free energy barrier. Furthermore, we were able to kinetically and thermodynamically describe the binding process and did not only identify a two-step binding mechanism, but we also found a strong population shift upon affinity maturation toward the native binding pose. Frontiers Media S.A. 2021-04-20 /pmc/articles/PMC8093575/ /pubmed/33959632 http://dx.doi.org/10.3389/fmolb.2021.639166 Text en Copyright © 2021 Fernández-Quintero, Seidler, Quoika and Liedl. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Fernández-Quintero, Monica L.
Seidler, Clarissa A.
Quoika, Patrick K.
Liedl, Klaus R.
Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics
title Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics
title_full Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics
title_fullStr Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics
title_full_unstemmed Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics
title_short Shark Antibody Variable Domains Rigidify Upon Affinity Maturation—Understanding the Potential of Shark Immunoglobulins as Therapeutics
title_sort shark antibody variable domains rigidify upon affinity maturation—understanding the potential of shark immunoglobulins as therapeutics
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093575/
https://www.ncbi.nlm.nih.gov/pubmed/33959632
http://dx.doi.org/10.3389/fmolb.2021.639166
work_keys_str_mv AT fernandezquinteromonical sharkantibodyvariabledomainsrigidifyuponaffinitymaturationunderstandingthepotentialofsharkimmunoglobulinsastherapeutics
AT seidlerclarissaa sharkantibodyvariabledomainsrigidifyuponaffinitymaturationunderstandingthepotentialofsharkimmunoglobulinsastherapeutics
AT quoikapatrickk sharkantibodyvariabledomainsrigidifyuponaffinitymaturationunderstandingthepotentialofsharkimmunoglobulinsastherapeutics
AT liedlklausr sharkantibodyvariabledomainsrigidifyuponaffinitymaturationunderstandingthepotentialofsharkimmunoglobulinsastherapeutics